Publications by authors named "R G Abadie"
Introduction: The full extent of interactions between human immunodeficiency virus (HIV) infection, injection drug use, and the human microbiome is unclear. In this study, we examined the microbiomes of HIV-positive and HIV-negative individuals, both drug-injecting and non-injecting, to identify bacterial community changes in response to HIV and drug use. We utilized a well-established cohort of people who inject drugs in Puerto Rico, a region with historically high levels of injection drug use and an HIV incidence rate disproportionately associated with drug use.
View Article and Find Full Text PDFBackground: Little is known about the prevalence of injection drug use in people with disabilities (PWD) when compared by disability type and to other adults without disabilities.
Objective Or Hypothesis: The prevalence of past-year injection drug use will be higher in adults with a reported disability than adults without any reported disability.
Methods: This study consisted of secondary analyses of data from the 2015-2019 National Survey of Drug Use and Health.
Article Synopsis
- * Treatment typically involves a combination of four medications, each targeting different aspects of the bacteria, but they all come with significant and sometimes debilitating side effects.
- * The side effects, including neuropathy from isoniazid and optic neuropathy from ethambutol, may lead to higher rates of noncompliance with treatment, indicating a need for better management strategies.
Background: During the COVID-19 pandemic, clinics offering medication for opioid use disorder (MOUD) needed to rapidly introduce unsupervised take-home dosing, while relapsing patients and patients unable to enter treatment faced increased risks of fentanyl-related overdose deaths and other drug-related harms. Based on a qualitative study of people who inject drugs (PWID) receiving MOUD treatment and MOUD staff in Puerto Rico, this paper documents the lived experiences of patients and providers during this period and the risk perceptions and management strategies to address substance misuse and drug diversion attributable to unsupervised take-home-dose delivery.
Methods: In-depth qualitative interviews were conducted with patients (N = 25) and staff (N = 25) in two clinics providing MOUD in San Juan, Puerto Rico, during 2022.